Biomanufacturing APAC 2018

Call for Papers

Join us, as Proventa International brings “Biomanufacturing Strategy Meeting APAC 2018”. Happening on May 7, 2018 at Swissotel Merchant Court Singapore. We will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Biomanufacturing. Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: – Process R&T/R&D/Development & Engineering, Upstream Drug Substance Development and Technology Management, Cell Culture Manufacturing/Cell Line Engineering, Purification Development, Preclinicial Manufacturing, Technology and Standardisation, Quality Operations/Quality Sciences Compliance and Analytical Technology, Validation Manufacturing Science,Risk Management, Bioprocessing R&D Analytics, CMC, Early Stage Bioprocess Development, Product Supply.

Speakers: 

Gary Khoo

APAC MSAT Head, Shire

Albert Cheong

Head of MSAT Upstream APAC, Merck

Ravi Kiran

Quality Director, Tessa Therapeutics

Sanjeev Gupta

GM and Biotech Head, IPCA Laboratories Ltd.

Nigel Cheong

Biomedical Sciences Head, Singapore Economic Development Board

Ronan McGarvey

Director for Quality Operations, AbbVie Singapore

Zhiwei Song

Principal Bioprocessing Scientist, Bioprocessing Technology Institute, A*Star, Singapore

Register now and Book your seat. Limited slots only!

https://proventainternational.com/biomanufacturing-apac/

See you there!